» Articles » PMID: 25192469

Insights into the Classification of Myasthenia Gravis

Overview
Journal PLoS One
Date 2014 Sep 6
PMID 25192469
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Myasthenia gravis (MG) is often categorized into thymoma-associated MG, early-onset MG with onset age <50 years, and late-onset MG with onset age ≥50 years. However, the boundary age of 50 years old between early- and late-onset MG remains controversial, and each category contains further subtypes. We attempted to classify MG from a statistical perspective.

Methods: We analyzed 640 consecutive MG patients using two-step cluster analysis with clinical variables and discrimination analysis, using onset age as a variable.

Results: Two-step cluster analyses categorized MG patients into the following five subtypes: ocular MG; MG with thymic hyperplasia (THMG); generalized anti-acetylcholine receptor antibody (AChR-Ab)-negative MG; thymoma-associated MG; and generalized AChR-Ab-positive (SP) MG without thymic abnormalities. Among these 5 subtypes, THMG showed a distribution of onset age skewed toward a younger age (p<0.01), whereas ocular MG and SPMG without thymic abnormalities showed onset age skewed toward an older age (p<0.001 and p<0.0001, respectively). The other 2 subtypes showed normal distributions. THMG appeared as the main component of early-onset MG, and ocular MG and SPMG without thymic abnormalities as the main components of late-onset MG. Discrimination analyses between THMG and ocular MG and/or SPMG without thymic abnormalities demonstrated a boundary age of 45 years old.

Conclusions: From a statistical perspective, the boundary age between early- and late-onset MG is about 45 years old.

Citing Articles

[Clinical course of myasthenia gravis at the department of neurology in Antananarivo Madagascar].

Razafindrasata S, Razafimahefa J, Lemahafaka G, Zodaly N, Tehindrazanarivelo A Pan Afr Med J. 2021; 37:304.

PMID: 33654523 PMC: 7896531. DOI: 10.11604/pamj.2020.37.304.18733.


MGTX extension study longitudinally favors early thymectomy in non-thymomatous young-adult patients with AChR antibody-positive myasthenia gravis.

Akaishi T, Motomura M, Aoki M, Utsugisawa K Ann Transl Med. 2019; 7(Suppl 6):S208.

PMID: 31656787 PMC: 6789369. DOI: 10.21037/atm.2019.06.65.


Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.

Massa R, Greco G, Testi M, Rastelli E, Terracciano C, Frezza E J Neurol. 2019; 266(4):982-989.

PMID: 30741378 DOI: 10.1007/s00415-019-09225-z.


Response to treatment of myasthenia gravis according to clinical subtype.

Akaishi T, Suzuki Y, Imai T, Tsuda E, Minami N, Nagane Y BMC Neurol. 2016; 16(1):225.

PMID: 27855632 PMC: 5114805. DOI: 10.1186/s12883-016-0756-3.


Precision medicine in myasthenia graves: begin from the data precision.

Li H, Hong Y, Xie Y, Hao H, Sun R Ann Transl Med. 2016; 4(6):106.

PMID: 27127759 PMC: 4828738. DOI: 10.21037/atm.2016.02.16.


References
1.
Jaretzki 3rd A, Barohn R, Ernstoff R, Kaminski H, KEESEY J, Penn A . Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 2000; 55(1):16-23. DOI: 10.1212/wnl.55.1.16. View

2.
Olsen S, Martuzzi M, Elliott P . Cluster analysis and disease mapping--why, when, and how? A step by step guide. BMJ. 1996; 313(7061):863-6. PMC: 2359075. DOI: 10.1136/bmj.313.7061.863. View

3.
Utsugisawa K, Suzuki S, Nagane Y, Masuda M, Murai H, Imai T . Health-related quality-of-life and treatment targets in myasthenia gravis. Muscle Nerve. 2014; 50(4):493-500. DOI: 10.1002/mus.24213. View

4.
Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Strobel P . The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev. 2013; 12(9):875-84. DOI: 10.1016/j.autrev.2013.03.007. View

5.
Suzuki S, Utsugisawa K, Suzuki N . Overlooked non-motor symptoms in myasthenia gravis. J Neurol Neurosurg Psychiatry. 2012; 84(9):989-94. DOI: 10.1136/jnnp-2012-304057. View